746 related articles for article (PubMed ID: 29463395)
41. Prevention of hypertension and its complications: theoretical basis and guidelines for treatment.
Flack JM; Peters R; Shafi T; Alrefai H; Nasser SA; Crook E
J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S92-8. PubMed ID: 12819310
[TBL] [Abstract][Full Text] [Related]
42. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
Ravera M; Paoletti E
Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
[TBL] [Abstract][Full Text] [Related]
43. Importance of modulating the renin-angiotensin system in preventing renal complications of hypertension.
Rayner B
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):469-80. PubMed ID: 17186680
[TBL] [Abstract][Full Text] [Related]
44. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
45. Current concepts in the management of diabetic nephropathy.
Waanders F; Visser FW; Gans RO
Neth J Med; 2013 Nov; 71(9):448-58. PubMed ID: 24218418
[TBL] [Abstract][Full Text] [Related]
46. Diabetes and hypertension.
Waeber B; Feihl F; Ruilope L
Blood Press; 2001; 10(5-6):311-21. PubMed ID: 11822535
[TBL] [Abstract][Full Text] [Related]
47. Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients.
So WY; Ozaki R; Chan NN; Tong PC; Ho CS; Lam CW; Ko GT; Chow CC; Chan WB; Ma RC; Chan JC
Hypertension; 2004 Sep; 44(3):294-9. PubMed ID: 15249544
[TBL] [Abstract][Full Text] [Related]
48. High mortality and poor quality of life during predialysis period in type II diabetic patients with diabetic nephropathy.
Biesenbach G; Zazgornik J
Ren Fail; 1994; 16(2):263-72. PubMed ID: 8041965
[TBL] [Abstract][Full Text] [Related]
49. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
50. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
[TBL] [Abstract][Full Text] [Related]
51. Type 2 diabetes mellitus: prevention of macrovascular complications.
Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
[TBL] [Abstract][Full Text] [Related]
52. Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy.
Athyros VG; Mitsiou EK; Tziomalos K; Karagiannis A; Mikhailidis DP
Expert Opin Pharmacother; 2010 Apr; 11(5):723-30. PubMed ID: 20210681
[TBL] [Abstract][Full Text] [Related]
53. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
Fragoso A; Mendes F; Silva AP; Neves PL
J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
[TBL] [Abstract][Full Text] [Related]
54. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
55. Losartan in diabetic nephropathy.
Perico N; Ruggenenti P; Remuzzi G
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
[TBL] [Abstract][Full Text] [Related]
56. When to start dialysis in diabetic patients?
de Alvaro F
EDTNA ERCA J; 2004; 30(3):143-7. PubMed ID: 15715117
[TBL] [Abstract][Full Text] [Related]
57. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
[TBL] [Abstract][Full Text] [Related]
58. Hypertension in diabetes mellitus.
Hasslacher C; Ritz E; Tschöpe W; Gallasch G; Mann JF
Kidney Int Suppl; 1988 Sep; 25():S133-7. PubMed ID: 3184604
[No Abstract] [Full Text] [Related]
59. Diabetic nephropathy: implications for renal and cardiovascular outcomes.
Folan LA; Tuttle KR
Minerva Med; 2004 Oct; 95(5):385-94. PubMed ID: 15467514
[TBL] [Abstract][Full Text] [Related]
60. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
